Biomatrica

The tubes enable noninvasive collection and preservation of biomarkers, such as circulating or total nucleic acids, and protein and cellular biomarkers.

NEW YORK (GenomeWeb) – Biomatrica has received a $1 million grant to develop a blueprint and functional prototype of an ambient temperature biobank for the US Army.

NEW YORK (GenomeWeb) – Microbiologics today announced it has licensed Biomatrica's technology for use in its molecular controls for rapid diagnostic instruments and assays.

Biomatrica said this week that Nicolas Barthelemy has been added to the company's board of directors while Jeff Whitmore has joined the company as vice president of commercial development.

NEW YORK (GenomeWeb News) — Biomatrica said today that it has signed a worldwide distribution agreement with Sigma-Aldrich for its biomolecule stabilization products.

NEW YORK (GenomeWeb News) – Biomatrica and ATCC today said they have completed a licensing agreement to supply reagents for stabilizing DNA and RNA standards.

NEW YORK (GenomeWeb News) – In June, Veracyte entered into a loan and security agreement with an unnamed financial institution for term loans of up to $10.0 million in aggregate, the company said in its recent Form 10-Q filed with the US Securities and Exchange Commission.

Biomatrica said today that it has raised $5 million in private financing.
The San Diego-based company said that it would use the funding to strengthen its research initiatives, increase manufacturing capabilities, and improve company infrastructure.

NEW YORK (GenomeWeb News) – Biomatrica said today that it has raised $5 million in private financing.
The San Diego-based company said that it would use the funding to strengthen its research initiatives, increase manufacturing capabilities, and improve company infrastructure.

Biomatrica this week launched three new products: Vacuette DNAgard blood tubes to collect, preserve, and ship DNA in whole blood at ambient temperatures; DNAstable Plus, a liquid stabilizer that preserves DNA in both liquid and dry formats; and

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.